Skip to main content
. 2011 Aug 8;31(10):1254–1263. doi: 10.1038/onc.2011.319

Table 1. Clinical/pathological characteristics of patient samples.

Age Margins Gleason sum Gleason primary Gleason secondary Gleason tertiary Pstage
39 Negative 7 4 3   T3AN0MX
52 Negative 6 3 3   T2N0MX
54 Positive 7 4 3 5 T3AN0MX
54 Negative 6 3 3   T2N0MX
55 Negative 7 3 4   T3BN0MX
56 Negative 9 4 5 3 T2N0MX
56 Negative 7 3 4   T3AN0MX
57 Positive 6 3 3   T3AN0MX
57 Positive 7 3 4   T3AN0MX
58 Negative 7 4 3 5 T3BN0MX
58 Positive 7 3 4   T3AN0MX
58 Negative 7 4 3   T3BN0MX
59 Negative 7 3 4   T3BN0MX
60 Negative 7 3 4   T3AN0MX
61 Negative 7 4 3 5 T3AN0MX
61 Negative 7 3 4   T2N0MX
62 Negative 7 3 4 5 T3AN0MX
62 Positive 8 4 4 5 T3AN0MX
63 Positive 7 3 4   T3AN0MX
65 Negative 7 3 4   T2N0MX
65 Negative 7 3 4 5 T3AN0MX

These are data from the radical prostatectomy specimens. PStage indicates pathological stage (AJCC/UICC, seventh edition) at radical prostatectomy. There were 18 Caucasian and 2 African-American patients.